Genetic Technologies (ASX:GTG) Common Stock: A$163.82 Mil (As of Jun. 2024)


What is Genetic Technologies Common Stock?

Genetic Technologies ASX:GTG Common Stock is A$163.82 Mil as of Jun. 2024.

Genetic Technologies's quarterly common stock declined from Dec. 2023 (A$161.34 Mil) to Mar. 2024 (A$0.00 Mil) but then increased from Mar. 2024 (A$0.00 Mil) to Jun. 2024 (A$163.82 Mil).

Genetic Technologies's annual common stock increased from Jun. 2022 (A$155.14 Mil) to Jun. 2023 (A$161.34 Mil) and increased from Jun. 2023 (A$161.34 Mil) to Jun. 2024 (A$163.82 Mil).

Genetic Technologies Common Stock Historical Data

* Premium members only.

The historical data trend for Genetic Technologies's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Technologies Common Stock Chart

Genetic Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140.11 153.58 155.14 161.34 163.82

Genetic Technologies Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 161.34 0.00 163.82 0.00

Genetic Technologies Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$163.82 Mil mean?
Genetic Technologies (ASX:GTG) has a Common Stock of A$163.82 Mil as of Jun. 2024. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Genetic Technologies and its competitors.
Is Genetic Technologies' Common Stock too high?
Genetic Technologies' current Common Stock is A$163.82 Mil.
How does Genetic Technologies' Common Stock compare to LDDD and NOTV?
Genetic Technologies' Common Stock of A$163.82 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Genetic Technologies and its competitors. Genetic Technologies's current Common Stock is A$163.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetic Technologies stock overvalued right now?
Genetic Technologies (ASX:GTG) has a current Common Stock of A$163.82 Mil. The current Common Stock is A$163.82 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Genetic Technologies (ASX:GTG), the current Common Stock is A$163.82 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genetic Technologies Business Description

Address 60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.